5//SEC Filing
Erdtmann Rainer M 5
Accession 0000899243-23-004578
CIK 0001840439other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:20 PM ET
Size
26.1 KB
Accession
0000899243-23-004578
Insider Transaction Report
Form 5
Erdtmann Rainer M
DirectorSee Remarks
Transactions
- Gift
Common Stock
2022-12-28−4,000→ 808,027 total - Gift
Common Stock
2022-12-28−70,000→ 734,027 total - Gift
Common Stock
2022-07-01−100,000→ 849,127 total - Gift
Common Stock
2022-08-16−17,100→ 832,027 total - Gift
Common Stock
2022-08-19−16,000→ 816,027 total - Gift
Common Stock
2022-12-28−4,000→ 812,027 total - Gift
Common Stock
2022-12-28+4,000→ 6,400 total(indirect: By daughter) - Gift
Common Stock
2022-12-28+4,000→ 7,000 total(indirect: By daughter) - Gift
Common Stock
2022-12-28−4,000→ 804,027 total - Gift
Common Stock
2022-12-28+4,000→ 7,000 total(indirect: By son)
Holdings
- 174,614(indirect: See Footnote)
Common Stock
- 1,134,989(indirect: See Footnote)
Common Stock
- 228,470(indirect: See Footnote)
Common Stock
- 252,320(indirect: See Footnote)
Common Stock
Footnotes (8)
- [F1]Includes 873,068 shares received prior to the gift in a distribution-in-kind, without consideration, from Biomea Health, LLC made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F2]Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- [F3]Includes 174,614 shares received in a prior distribution-in-kind, without consideration, from Biomea Health, LLC made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Exchange Act.
- [F4]The shares are held by a trust having an independent trustee ("Trust 1"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F5]Includes 1,134,989 shares received in a prior distribution-in-kind, without consideration, from Biomea Health, LLC made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Exchange Act.
- [F6]The shares are held by a trust having an independent trustee ("Trust 2"). The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F7]The shares are held directly by Point Sur Investors Fund I, LP ("Point Sur LP"). The General Partner of Point Sur LP is Point Sur Investors LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur LP. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F8]The shares are held directly by Point Sur Investors, LLC. Rainer M Erdtmann and Thomas Butler are the managing members of Point Sur Investors, LLC and as such have voting and dispositive power over the securities held by Point Sur Investors, LLC. The Reporting Person disclaims Section 16 beneficial ownership of the securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
Related Parties
1- filerCIK 0001455767
Filing Metadata
- Form type
- 5
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:20 PM ET
- Size
- 26.1 KB